Gold Nanoparticles News and Research

RSS

Gold nanoparticles are made up of metallic gold atoms to create a crystal structure of 1-100 nm.

Researchers develop new method for remotely stimulating activity in deep brain regions

University of Texas at Dallas researchers have developed a promising method for remotely stimulating activity in deep brain regions, advancing understanding of how molecules act in the brain and paving the way for better cancer treatments and therapies for other diseases.

27 Apr 2020

McKelvey engineers receive federal funding for rapid COVID-19 test

Engineers at the McKelvey School of Engineering at Washington University in St. Louis have received federal funding for a rapid COVID-19 test using a newly developed technology.

20 Apr 2020

Researchers develop a faster, more accurate COVID-19 test

Millions of people have been tested for the novel coronavirus, most using a kit that relies on the polymerase chain reaction.

15 Apr 2020

Building a 3D scaffolding to monitor tumor growth in real time and controlled environments

Building three-dimensional scaffolding to guide the growth of tumors in controlled environments, to monitor the evolution of each of their cells in real time and to record the release of tumor metabolites and other indicators of cell activity under different conditions.

9 Mar 2020

Advanced hollow nanomaterials can be used to create biosensors for early cancer detection

For the first time, a team of scientists at the University of Central Florida has created functional nanomaterials with hollow interiors that can be used to create highly sensitive biosensors for early cancer detection.

26 Feb 2020

UT Dallas scientists awarded CPRIT grants for lung, kidney cancer research

The Cancer Prevention and Research Institute of Texas has awarded new grants totaling $1.8 million to two University of Texas at Dallas scientists for their research related to lung and kidney cancers.

23 Feb 2020

Novel tool monitors influenza A virus mutations in real time

A Rutgers-led team has developed a tool to monitor influenza A virus mutations in real time, which could help virologists learn how to stop viruses from replicating.

6 Feb 2020

New achievement with 3D-printing could have applications in pharmaceutical industry

University of Seville researchers, in collaboration with the University of Nottingham, have managed to create the first image of nanoparticles of stabilized gold with biodegradable and biocompatible systems that have been obtained with 3D-printng techniques.

17 Jan 2020

Super fast novel device catches and identifies viruses

A new study published in the journal Proceedings of the National Academy of Sciences on December 23, 2019, describes a novel device developed by a team of researchers at Penn State and New York University. Not only can this instrument capture different types of virus, it can tell what kind they are.

23 Dec 2019

New technique could lead to better diagnosis and effective tracking of Huntington’s disease

Researchers at the universities of Southampton and Cambridge have developed a new technique to analyze biochemical changes unique to Huntington's disease.

17 Dec 2019

Leading researchers attend 3rd Annual Postnova Analytics FFF User Meeting

The 3rd Annual Postnova Analytics Field Flow Fractionation User Meeting was recently held on October 4, 2019 in Boston, MA (USA).

From Postnova Analytics 11 Nov 2019

Nanomeshes could be effective drug delivery system for antibiotics

The fight against global antibiotic resistance has taken a major step forward with scientists discovering a concept for fabricating nanomeshes as an effective drug delivery system for antibiotics.

16 Oct 2019

Discovery of neoantigens could widen the possibilities for universal cancer vaccine

For more than a decade, scientist Stephen Albert Johnston and his team at Arizona State University's Biodesign Institute have pooled their energies into an often scoffed-at, high-risk, high-reward goal in medicine: to develop a universal vaccine to prevent cancer.

2 Oct 2019

Gold nanoparticles used successfully in prostate tumour trial

Researchers at the Icahn School of Medicine, Mount Sinai, New York have reported a pilot clinical trial with a “nanoparticle-based photothermal cancer therapy” for prostate cancers. Their work with this targeted therapy is published in a study titled, “Gold nanoshell-localized photothermal ablation of prostate tumors in a clinical pilot device study,” in the latest issue of the journal Proceedings of National Academy of Science.

28 Aug 2019

Gold nanoparticles shown to safely, effectively ablate low- to intermediate-grade prostate tumors

Biocompatible gold nanoparticles designed to convert near-infrared light to heat have been shown to safely and effectively ablate low- to intermediate-grade tumors within the prostate, according to a study conducted at the Icahn School of Medicine and published in the journal Proceedings of the National Academy of Sciences.

27 Aug 2019

Harnessing power of CRISPR to control behavior of DNA-responsive materials

The CRISPR-Cas system has become the go-to tool for researchers who study genes in an ever-growing list of organisms, and is being used to develop new gene therapies that potentially can correct a defect at a single nucleotide position of the vast reaches of the genome.

23 Aug 2019

Nanoparticles' movements reveal whether they can hit intended cancer targets

Targeted drug-delivery systems hold significant promise for treating cancer effectively by sparing healthy surrounding tissues. But the promising approach can only work if the drug hits its target.

10 Aug 2019

Scientists redesign chemotaxis by creating artificial nanoswimmers from gold nanoparticles

Bacteria can actively move towards a nutrient source—a phenomenon known as chemotaxis—and they can move collectively in a process known as swarming.

1 Aug 2019

Pharmaceutical products made of solid gold

Over the past twenty years, the use of nanoparticles in medicine has steadily increased. However, their safety and effect on the human immune system remains an important concern.

28 Jun 2019

UAMS-developed noninvasive device detects melanoma in earliest stages

A University of Arkansas for Medical Sciences research team led by Vladimir Zharov, Ph.D., D.Sc., has demonstrated the ability to detect and kill circulating tumor cells in the blood using a noninvasive device called Cytophone that integrates a laser, ultrasound and phone technologies.

13 Jun 2019